Alternatively Speaking

  • Home
  • KCSA Cannabis
  • Listen
    • On iTunes
    • On Spotify
    • Archive
  • Advertise
  • About Us

  • Home
  • KCSA Cannabis
  • Listen
    • On iTunes
    • On Spotify
    • Archive
  • Advertise
  • About Us
2333

Dr. Peter Diamandis, Futurist of AI & Human Longevity

by Maria Petsanas on October 22, 2024 in podcast

https://media.blubrry.com/3739642/ins.blubrry.com/3739642/Alt_Speaking_Peter_D_FULL_SHOW.mp3

Welcome to Alternatively Speaking, a KCSA Podcast Labs production. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare.

Today, our host sat down with Dr. Peter Diamandis, a visionary at the forefront of the longevity revolution. Named by Fortune as one of the “World’s 50 Greatest Leaders,” Diamandis has started over 20 companies in the areas of longevity, space, venture capital, and education. 

Diamandis is the founder & executive chairman of the XPRIZE Foundation, which leads the world in designing & operating large-scale incentive competitions. He is also the co-founder and vice-chairman of Human Longevity Inc., merging advanced genomic sequencing with AI to develop therapies aimed at slowing down or even reversing aging. Additionally, Diamandis co-founded Fountain Life with Tony Robbins, a unique concierge healthcare company dedicated to revolutionizing the healthcare industry. Diamandis is the creator of Abundance360, a year-round program for entrepreneurs, investors, and executives focused on leveraging technology to drive positive change and leave a legacy.

Diamandis is a New York Times Bestselling author of three books: Abundance – The Future Is Better Than You Think, BOLD – How to go Big, Create Wealth & Impact the World and The Future is Faster Than You Think. He is also the executive founder of Singularity University, a graduate-level Silicon Valley institution that counsels the world’s leaders on exponentially growing technologies.

Podcast Highlights:

  1. Introduction & Dr. Diamandis’ Motivations (4:01): Discussion of Diamandis’ reasons for focusing on longevity, including its potential as a gift to humanity and a major business opportunity.
  2. Envisioning Extended Lifespans (6:55): Exploration of how life might change with significantly extended lifespans and Diamandis’ personal perspective on living to 150 or beyond.
  3. Ethical Considerations of Longevity (10:24): Addressing concerns about overpopulation and resource depletion, with Diamandis’ optimistic view on technological solutions.
  4. Breakthrough Technologies in Longevity (15:58): Overview of AI’s potential role in understanding aging and discussion of the $101 million XPRIZE Healthspan.
  5. Fountain Life and Preventative Diagnostics (23:25): Introduction to Fountain Life’s comprehensive health assessment approach and statistics on early disease detection.
  6. Personal Health Practices (35:56): Diamandis’ approach to diet, exercise, and supplements, with emphasis on reducing sugar intake and increasing vegetable consumption.
  7. Investment in Longevity Science (38:28): Advice for potential investors in the longevity space and discussion of challenges in biotech investments.
  8. Singularity and AI (42:24): Explanation of Ray Kurzweil’s concept of the “singularity” and Diamandis’ perspective on the rapid advancement of AI.

Guest Social Media:

  • LinkedIn: https://www.linkedin.com/in/peterdiamandis/
  • X: @PeterDiamandis

Other Links/Mentions/Resources:

  • Peter Diamandis Website: https://www.diamandis.com/ 
  • Books by Peter Diamandis: https://www.diamandis.com/books 
  • Human Longevity Inc.: https://www.humanlongevity.com/ 
  • XPRIZE Foundation: https://www.xprize.org/ 
  • Fountain Life: https://www.fountainlife.com/ 
  • Singularity University: https://su.org/ 
  • Abundance360: https://www.abundance360.com/summit 
  • All affiliated companies and foundations: https://www.diamandis.com/companies 

Show Credits:

This episode was hosted by Lewis Goldberg of KCSA Strategic Communications. 

Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing AltSpeaking@kcsa.com. You can also connect with us via our social channels:

  • X: @KCSAPodcastLabs
  • Instagram: @KCSAPodcastLabs
  • LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/
Share Post

More Episodes

Longevity Reflections & AI Preview – S1 Finale

Welcome to Alternatively Speaking, a KCSA Podcast Labs production. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare. For our final episode of the season, hosts Lewis Goldberg, Phil Carlson, and Anne Donohoe reflect on their journey through the world of longevity science and discuss key learnings from […]

Sebastian Brunemeier, Longevity Biotech, Life Extension & the Next Era of Medicine

Welcome to Alternatively Speaking, a KCSA Podcast Labs production. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare.  Today, our hosts engage in a fascinating discussion with Sebastian Brunemeier, a true powerhouse in the longevity and regenerative medicine space. Sebastian is a biotech venture capitalist and company builder […]

Petr Sramek, Investing in Longevity Tech

Welcome to Alternatively Speaking, a KCSA Podcast Labs production. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare.  Today, our hosts Phil Carlson and Anne Donohoe dive into the world of longevity technology with guest Petr Sramek, a visionary in the field of longevity tech. Petr is the […]

Lou Reese, Next-Gen Vaccines

Welcome to Alternatively Speaking, a KCSA Podcast Labs production. In our debut season, we’re diving into a revolutionary concept in health span, longevity, and healthcare.  Today, our host sat down with Lou Reese, co-founder and Vice Chairman of Vaxxinity, a purpose-driven biotechnology company pioneering a new class of medicines aimed at disrupting existing treatments for […]

Load More

261 Madison Ave.
9th Floor New York,
NY 10016

© 2025 KCSA Strategic Communications. All Rights Reserved

  • Privacy Policy
  • Disclaimer
×